Yeo-Pyo Yun Selected Research

Yeo-Pyo Yun Research Topics

Disease

12	Atherosclerosis 07/2013 - 02/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 02/2014 - 01/2003
8	Neoplasms (Cancer) 02/2014 - 04/2007
5	Carotid Artery Injuries 12/2014 - 09/2004
5	Hyperplasia 07/2013 - 10/2007
5	Retinoblastoma (Glioblastoma, Retinal) 07/2012 - 05/2007
5	Thrombosis (Thrombus) 01/2011 - 02/2004
4	Inflammation (Inflammations) 05/2013 - 07/2010
3	Neointima 05/2013 - 06/2010
3	Edema (Dropsy) 06/2006 - 08/2003
2	Colonic Neoplasms (Colon Cancer) 02/2014 - 12/2013
2	Neuroinflammatory Diseases 03/2013 - 01/2013
2	Stomach Ulcer (Gastric Ulcer) 12/2012 - 12/2009
2	Hypertension (High Blood Pressure) 09/2011 - 07/2003
2	Carotid Artery Thrombosis 01/2011 - 10/2006
2	Ventricular Tachycardia 12/2005 - 08/2005
2	Premature Cardiac Complexes (Extrasystoles) 12/2005 - 08/2005
2	Ischemia 12/2005 - 08/2005
2	Infarction (Infarctions) 12/2005 - 08/2005
2	Heart Injuries 12/2005 - 08/2005
2	Ventricular Fibrillation 12/2005 - 08/2005
2	Myocardial Infarction 08/2005 - 07/2003
1	Obesity 02/2014
1	Melanoma (Melanoma, Malignant) 01/2012
1	Muscular Diseases (Myopathy) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 03/2010
1	Vascular Diseases (Vascular Disease) 11/2008
1	Atherosclerotic Plaque (Atheroma) 09/2007

Drug/Important Bio-Agent (IBA)

8	Becaplermin (PDGF-BB)FDA Link 05/2013 - 01/2007
4	CollagenIBA 12/2014 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 02/2014 - 10/2007
4	Biological ProductsIBA 12/2012 - 05/2008
4	obovatolIBA 12/2012 - 12/2009
3	sulforaphaneIBA 02/2014 - 07/2012
3	CytokinesIBA 02/2014 - 09/2007
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2013 - 07/2010
3	Cyclin EIBA 07/2010 - 05/2007
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2010 - 05/2007
3	Arachidonic Acid (Vitamin F)IBA 01/2008 - 01/2006
3	Platelet-Derived Growth FactorIBA 05/2007 - 01/2007
2	Adenosine Diphosphate (ADP)IBA 12/2014 - 10/2006
2	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 10/2007
2	isothiocyanic acidIBA 02/2014 - 07/2013
2	LipopolysaccharidesIBA 02/2014 - 01/2013
2	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2012 - 12/2009
2	SphingolipidsIBA 01/2012 - 08/2007
2	monomethylarsonous acidIBA 09/2011 - 11/2008
2	ArsenicIBA 09/2011 - 11/2008
2	Fenofibrate (CiL)FDA LinkGeneric 01/2011 - 10/2009
2	AntioxidantsIBA 07/2010 - 04/2007
2	ResveratrolIBA 07/2010 - 08/2003
2	CalciumIBA 10/2009 - 01/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2007 - 09/2007
2	SodiumIBA 12/2005 - 08/2005
2	Guanidine (Guanidine Nitrate)FDA Link 12/2005 - 08/2005
2	furanIBA 12/2005 - 08/2005
2	HydrogenIBA 12/2005 - 08/2005
2	TeaIBA 09/2004 - 02/2002
1	InterleukinsIBA 02/2014
1	p38 Mitogen-Activated Protein KinasesIBA 02/2014
1	Caspase 3 (Caspase-3)IBA 02/2014
1	Apoptosis Regulatory ProteinsIBA 02/2014
1	Inhibitor of Apoptosis ProteinsIBA 02/2014
1	Caspase 9IBA 12/2013
1	beta-thujaplicinIBA 12/2013
1	GinsenosidesIBA 05/2013
1	ginsenoside M1IBA 05/2013
1	Ethanol (Ethyl Alcohol)IBA 03/2013
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2013
1	thermozymocidin (myriocin)IBA 01/2012
1	Serine C-PalmitoyltransferaseIBA 01/2012
1	Cyclin B1IBA 01/2012
1	clitocybin BIBA 01/2012
1	Retinoblastoma ProteinIBA 01/2011
1	Cyclin DIBA 01/2011
1	Mitogen-Activated Protein KinasesIBA 01/2011
1	sauchinoneIBA 01/2011
1	Plant ExtractsIBA 01/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 07/2010
1	pterostilbeneIBA 07/2010
1	Cyclin D1IBA 07/2010
1	Pharmaceutical PreparationsIBA 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2010
1	BST 406IBA 01/2010
1	ThromboxanesIBA 10/2009
1	Arsenicals (Arsenic Compounds)IBA 11/2008
1	corynoxeineIBA 11/2008
1	Drinking WaterIBA 11/2008
1	Phosphotransferases (Kinase)IBA 05/2008
1	YSK 2821IBA 05/2008
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2008
1	gallocatechol (epigallocatechin)IBA 01/2008
1	desoxyepothilone B (epothilone D)IBA 10/2007
1	cudraflavanone AIBA 09/2007
1	FumonisinsIBA 08/2007
1	dihydroceramide desaturaseIBA 08/2007
1	epothilone B (EPO906)IBA 05/2007

Therapy/Procedure

2	Oral Administration 12/2014 - 01/2011
1	Therapeutics 07/2013